Showing results (21-30 of 81) with videos related to

Sort By:
Pageof 9
The Review of Diabetic Studies : RDS|May 10, 2007
Pregnancy outcome in type 2 diabetes mellitus: a retrospective analysis from the NetherlandsHarold W de Valk, Nancy H G van Nieuwaal, Gerard H A Visser
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|September 4, 2012
Gestational diabetes mellitus diagnosed by screening or symptoms: does it matter?Nurah M Hammoud, Harold W de Valk, Douwe H Biesma, et al.
The Journal of Clinical Endocrinology and Metabolism|August 23, 2020
Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) in Patients With Type 1 Diabetes Mellitus: A Systematic Review and Meta-AnalysisMarieke de Vries, Jan Westerink, Karin H A H Kaasjager, et al.
Neonatology|October 28, 2016
Intrauterine Adiposity and BMI in 4- to 5-Year-Old Offspring from Diabetic PregnanciesNurah M Hammoud, Harold W de Valk, Douwe H Biesma, et al.
The Journal of Family Practice|May 6, 2004
Starting insulin in type 2 diabetes: continue oral hypoglycemic agents? A randomized trial in primary careAlex N Goudswaard, Ronald P Stolk, Peter Zuithoff, et al.
Diabetes Technology & Therapeutics|August 7, 2010
Glycemic variability in inadequately controlled type 1 diabetes and type 2 diabetes on intensive insulin therapy: a cross-sectional, observational studyWendela L Greven, Joline W J Beulens, Douwe H Biesma, et al.
Clinics (Sao Paulo, Brazil)|August 19, 2023
The prevalence of vascular and metabolic complications after lung transplant in people with cystic fibrosis in a Dutch cohortLisa M Oppelaar, Bart Luijk, Harry G M Heijerman, et al.
Diabetes Research and Clinical Practice|March 14, 2022
Prevalence of non-alcoholic fatty liver disease (NAFLD) and its association with surrogate markers of insulin resistance in patients with type 1 diabetesMarieke de Vries, Jan Westerink, Fatima El-Morabit, et al.
Clinicoeconomics and Outcomes Research : CEOR|January 26, 2019
Cost-effectiveness of sensor-augmented insulin pump therapy vs continuous subcutaneous insulin infusion in patients with type 1 diabetes in the NetherlandsStephané Roze, Jayne Smith-Palmer, Simona de Portu, et al.
Diabetes, Obesity & Metabolism|November 4, 2016
Effect modification in the association between glycated haemoglobin and cardiovascular disease and mortality in patients with type 2 diabetesSanne N van Munster, Yolanda van der Graaf, Harold W de Valk, et al.
Pageof 9